Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001214659-26-000187
Filing Date
2026-01-06
Accepted
2026-01-06 16:05:11
Documents
1
Period of Report
2026-01-06

Document Format Files

Seq Description Document Type Size
1 i162616k.htm 6-K 11424
  Complete submission text file 0001214659-26-000187.txt   12685
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF United Kingdom CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF United Kingdom CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37652 | Film No.: 26511400
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)